Skip to content
Screener

Bruker BRKR EPS (Diluted)

EPS (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$4.68+9.3%
Danaher logo
DanaherDHR
$1.23+59.7%
TEC
Bio-TechneTECH
$0.32+129%
WAT
Waters CorporationWAT
$1.39-43.7%
Agilent Technologies logo
Agilent TechnologiesA
$1.20+60.0%
908 Devices logo
908 DevicesMASS
-$0.32-126%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Bruker’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:24 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335226
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Dividends on Series A Mandatory Convertible Preferred Stock10.921.8
Net (loss) income attributable to Bruker Corporation common shareholders$(62.9)$7.6$(59.4)$25.0
Net (loss) income per common share attributable to Bruker Corporation common shareholders:
Basic$(0.41)$0.05$(0.39)$0.16
Diluted$(0.41)$0.05$(0.39)$0.16
Weighted average common shares outstanding:
Basic152.3151.6152.2151.6
Diluted152.3151.7152.2151.8

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's EPS (diluted)?
Bruker (BRKR) reported EPS (diluted) of -$0.41 in Q2 2026.
How has Bruker's EPS (diluted) changed year-over-year?
Bruker's EPS (diluted) decreased by 920.0% year-over-year, from $0.05 to -$0.41.
What is the long-term trend for Bruker's EPS (diluted)?
Over 3 years (2021 to 2024), Bruker's EPS (diluted) has grown at a -25.1% compound annual growth rate (CAGR), from $1.81 to $0.76.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Bruker's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude